Barrie Kellam

Professor of Medicinal Chemistry

University of Nottingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Barrie Kellam is a scholar in Medicinal Chemistry at the University of Nottingham, UK. His research predominantly focuses on the development of novel fluorescent ligands for various chemokine receptors, as evidenced by his recent publications. His work includes studies on adenosine A2B receptors, CXCR4, and glycoprotein VI, contributing significantly to the understanding of receptor interactions and drug delivery mechanisms.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (26)

Carl White

University of Western Australia

AUSTRALIA

Barrie Kellam

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)

A novel and selective fluorescent ligand for the study of adenosine A2B receptors

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans

Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization

Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor

Passerini chemistries for synthesis of polymer pro-drug and polymersome drug delivery nanoparticles

Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor

Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels

Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2.

Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells

Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers

Synthesis and matched molecular pair analysis of covalent reversible inhibitors of the cysteine protease CPB

Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor

Collaborators (26)

Carl White

Mark Thomas

Rekhati Abhayawardana

Steven M. Howdle

Natalie J. Jooss

Ángel García

Steve P. Watson

Jeanette Woolard

jillian baker

Henry Vischer

Meritxell Canals

Hester Franks

Michael Stocks

Luis Arturo Moran Lara

Shailesh N. Mistry

Joanne Clark

Alexandre Slater

Cameron Alexander

Chris de Graaf

Jonas Emsley

Eleyna Martin

Natalie Poulter

Stephen Hill

Laura E. Kilpatrick

Kevin Pfleger

Lauren T. May

Make your next move.